In a patient with white blood cell count 12.9 ×10⁹/L, red blood cell count 3.08 ×10¹²/L, hemoglobin 6.9 g/dL, hematocrit 23.8 %, MCH 22.4 pg, MCHC 29 g/dL, RDW 19.8 % and platelet count 748 ×10⁹/L, what is the appropriate management?

Immediate Transfusion and Urgent Hematologic Workup Required

This patient requires immediate red blood cell transfusion for severe anemia (hemoglobin 6.9 g/dL) and urgent evaluation for the underlying cause of combined severe microcytic anemia with marked thrombocytosis and elevated RDW.

Critical Management Steps

1. Immediate Transfusion

• Transfuse RBCs now to hemoglobin threshold of 7.0 g/dL minimum 1
• Consider higher threshold (8-9 g/dL) if patient has:
  • Active symptoms (dyspnea, chest pain, altered mental status)
  • Cardiovascular disease
  • Ongoing bleeding
  • Hemodynamic instability 2

2. Urgent Diagnostic Evaluation

This blood picture suggests iron deficiency anemia with reactive thrombocytosis, but requires immediate confirmation:

Key diagnostic features present:

• Severe microcytic anemia (MCH 22.4 pg, MCHC 29 g/dL - both low)
• High RDW (19.8%) indicating marked anisocytosis
• Extreme thrombocytosis (748 × 10⁹/L)
• Mild leukocytosis (12.9 × 10⁹/L)

Immediate laboratory tests needed:

• Iron studies: Serum ferritin, transferrin saturation (TSAT), serum iron 3
• Peripheral blood smear: Evaluate RBC morphology, rule out schistocytes, confirm platelet count
• Reticulocyte count: Assess bone marrow response 3
• Stool occult blood: Rule out GI bleeding
• Comprehensive metabolic panel: Assess renal function, electrolytes

Additional tests to consider:

• Vitamin B12 and folate levels 3
• Hemoglobin electrophoresis (if thalassemia suspected based on ethnicity/family history)
• Bone marrow evaluation if diagnosis remains unclear after initial workup

3. Differential Diagnosis Priority

Most likely: Severe iron deficiency anemia with reactive thrombocytosis

• The combination of severe microcytic anemia (low MCH, low MCHC), high RDW, and marked thrombocytosis is classic for chronic iron deficiency
• Platelet count >600 × 10⁹/L commonly occurs as reactive thrombocytosis in severe iron deficiency

Must rule out:

• Myeloproliferative neoplasm (essential thrombocythemia, polycythemia vera): The thrombocytosis is extreme, though anemia argues against PV 4
• Chronic myelomonocytic leukemia (CMML): WBC 12.9 with anemia and thrombocytosis requires peripheral smear review 5
• Thalassemia trait with concurrent iron deficiency: Would show microcytosis disproportionate to anemia severity
• Chronic GI bleeding: Most common cause of severe iron deficiency in adults

4. Source Control

Identify and address bleeding source:

• Detailed history: Menstrual bleeding (if applicable), GI symptoms, dietary history
• Physical examination: Signs of bleeding, hepatosplenomegaly, lymphadenopathy
• GI evaluation: Endoscopy if iron deficiency confirmed and no other obvious source
• Gynecologic evaluation if premenopausal female with heavy menses

5. Iron Replacement Strategy

If iron deficiency confirmed (ferritin <30 ng/mL or TSAT <20%):

• Intravenous iron preferred for severe anemia (hemoglobin <7-8 g/dL) for faster response 3
• Oral iron acceptable if:
  • Patient stable after transfusion
  • No malabsorption suspected
  • Can tolerate oral therapy
  • Dose: 100-200 mg elemental iron daily

6. Platelet Management

Do NOT treat thrombocytosis initially 4

• Reactive thrombocytosis from iron deficiency typically resolves with iron replacement
• If platelet count remains >600 × 10⁹/L after anemia correction, consider:
  • Hematology referral
  • JAK2, CALR, MPL mutation testing
  • Bone marrow biopsy to rule out essential thrombocythemia

Aspirin consideration:

• Low-dose aspirin (81 mg daily) if cardiovascular risk factors present
• Hold if active bleeding or platelet dysfunction suspected

Critical Pitfalls to Avoid

1. Do not delay transfusion while awaiting iron studies - severe symptomatic anemia requires immediate correction
2. Do not assume reactive thrombocytosis without confirming iron deficiency and excluding myeloproliferative disorders
3. Do not treat thrombocytosis with cytoreduction before establishing diagnosis
4. Do not miss occult malignancy - severe iron deficiency in adults warrants GI evaluation even without overt bleeding
5. Do not transfuse to "normal" hemoglobin - restrictive strategy (7-8 g/dL) reduces complications 1, 2

Follow-up Monitoring

• Recheck CBC in 1 week after transfusion and iron initiation
• Reticulocyte count should rise within 5-7 days if iron deficiency
• Platelet count should begin declining within 2-4 weeks with iron replacement
• If no response or platelets remain elevated, proceed with myeloproliferative workup